Role of the common γ chain in cell cycle progression of human malignant cell lines

International Immunology

Volumn 24, Issue 3, 2012, Pages 159-167

  Vigliano, Ilaria ^a   Palamaro, Loredana ^a   Bianchino, Gabriella ^b   Fusco, Anna ^a   Vitiello, Laura ^a   Grieco, Vitina ^b   Romano, Rosa ^a   Salvatore, Marco ^a,b   Pignata, Claudio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Cell proliferation; Cytokines; Gamma chain; SCID

Indexed keywords

BETA ACTIN; CASPASE 3; CYCLIN A2; CYCLIN B1; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYTOKINE RECEPTOR; CYTOKINE RECEPTOR GAMMA CHAIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; PROTEIN BCL 2; PROTEIN BCL XL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAUDI CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84857612926     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr114     Document Type: Article

References (48)

1. Leonard, W. J. 1996. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu. Rev. Med. 47:229.
2. Notarangelo, L. D., Giliani, S., Mazza, C. et al. 2000. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model. Immunol. Rev. 178:39.
3. c family cytokines. Nature Rev. Immunol. 9:480.
4. Yao, Z., Cui, Y., Watford, W. T. et al. 2006. Stat5a/b are essential for normal lymphoid development and differentiation. Proc. Natl Acad. Sci. USA 103:1000.
5. Moriggl, R., Topham, D. J., Teglund, S. et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249.
6. Lord, J. D., McIntosh, B. C., Greenberg, P. D. et al. 2000. The IL-2 receptor promotes lymphocyte proliferation and induction of the cmyc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J. Immunol. 164:2533.
7. Lockyer, H. M., Tran, E. and Nelson, B. H. 2007. STAT5 is essential for Akt/p.70S6 kinase activity during IL-2-induced lymphocyte proliferation. J. Immunol. 179:5301.
8. Barata, J. T., Keenan, T. D., Silva, A. et al. 2004. Common c chainsignaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia. Haematologica 89:1459.
9. Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P. et al. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118:3132.
10. Howe, S. J., Mansour, M. R., Schwarzwaelder, K. et al. 2008. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118:3143.
11. Amorosi, S., Russo, I., Amodio, G. et al. 2009. The cellular amount of the common c-chain influences spontaneous or induced cell proliferation. J. Immunol. 182:3304.
12. Maddika, S., Ande, S. R., Panigrahi, S. et al. 2007. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 10:13.
13. Sherr, C. J. and Roberts, J. M. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18:2699.
14. Lindemann, M. J., Benczik, M. and Gaffen, S. L. 2003. Antiapoptotic signalling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit. J. Biol. Chem. 278:10239.
15. Martino, A., Holmes, J. H. IV, Lord, J. D. et al. 2001. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-21. J. Immunol. 166:1723.
16. Moon, J. J., Rubio, E. D., Martino, A. et al. 2004. A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J. Biol. Chem. 279:5520.
17. Engedal, N., Gjevik, T., Blomhoff, R. et al. 2006. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: early induction of cyclin D3. J. Immunol. 177:2851.
18. Zinkel, S., Gross, A. and Yang, E. 2006. BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 13:1351.
19. Cooper, A. B., Sawai, C. M., Sicinska, E. et al. 2006. A unique function for cyclin D3 in early B cell development. Nat. Immunol. 7:489.
20. Pignata, C., Troncone, R., Monaco, G. et al. 1985. Impaired suppressor activity in children affected by coeliac disease. Gut 26:285.
21. -ΔΔCt method. Methods 25:402.
22. DeFranco, S., Bonissoni, S., Cerutti, F. et al. 2001. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 50:483.
23. Lamkanfi, M., Festjens, N., Declercq, W. et al. 2007. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 14:44.
24. Tait, S. W. G. and Green, D. R. 2008. Caspase independent cell death: leaving the set without the final cut. Oncogene 27:6452.
25. Haraguchi, B. M., Torii, S., Matsuzawa, S. et al. 2000. Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J. Exp. Med. 191:1709.
26. Hua, F., Cornejo, M. G., Cardone, M. H. et al. 2005. Effects of Bcl-2 levels on Fas signaling-induced Caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 175:985.
27. Zhou, F., Yang, Y. and Xing, D. 2011. Bcl-2 and Bcl-xL play important role in the crosstalk between autophagy and apoptosis. FEBS J. 278:403.
28. von Freeden-Jeffry, U., Solvason, N., Howard, M. et al. 1997. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7:147.
29. Akbar, A., Borthwick, N. J., Wickremasinghe, R. G. et al. 1996. Interleukin-2 receptor common c-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26:294.
30. Budirahardja, Y. and Gonczy, P. 2009. Coupling the cell cycle to development. Development 136:2861.
31. Ekberg, J., Holm, C., Jalili, S. et al. 2005. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome. Eur. J. Haematol. 75:106.
32. Davè, U. P., Akagi, K., Tripathi, R. et al. 2009. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet. 5:e1000491.
33. Aiuti, A., Cassani, B., Andolfi, G. et al. 2007. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J. Clin. Invest. 117:2233.
34. Deichmann, A., Hacein-Bey-Abina, S., Schmidt, M. et al. 2007. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J. Clin. Invest. 117:2225.
35. Woods, N. B., Bottero, V., Schmidt, M. et al. 2006. Woods et al. reply. Nature 443:E6.
36. Du, Y., Spence, S. E., Jenkins, N. A. et al. 2005. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood 106:2498.
37. Cornejo, M. G., Kharas, M. G., Werneck, M. B. et al. 2009. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood 113:2746.
38. Knoops, L., Hornakova, T., Royer, Y. et al. 2008. JAK kinases overexpression promotes in vitro cell transformation. Oncogene 27:1511.
39. Ambrosio, R., Fimiani, G., Monfregola, J. et al. 2002. The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter. Gene 285:311.
40. Harir, N., Pecquet, C., Kerenyi, M. et al. 2007. Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood 109:1678.
41. Yam, C. H., Fungand, T. K. and Poon, R. Y. C. 2002. Cyclin A in cell cycle control and cancer. Cell. Mol. Life Sci. 59:1317.
42. Yuan, J., Yan, R., Kramer, A. et al. 2004. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 23:5843.
43. Hochegger, H., Takeda, S. and Hunt, T. 2008. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nature 9:910.
44. Kalaszczynska, I., Geng, Y., Lino, T. et al. 2009. Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 138:352.
45. Landis, M. W., Pawlyk, B. S., Li, T. et al. 2006. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9:13.
46. Decker, T., Schneller, F., Hipp, S. et al. 2002. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p.27. Leukemia 16:327.
47. Sicinska, E., Aifantis, I., Le Cam, L. et al. 2003. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4:451.
48. Kozar, K., Ciemerych, M. A., Rebel, V. I. et al. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477.